Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016
- 1 January 1994
- journal article
- Published by Elsevier BV in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 266 (1), 57-62
- https://doi.org/10.1016/0922-4106(94)90209-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- [3H]R75231 — a new radioligand for the nitrobenzylthioinosine sensitive nucleoside transport proteins Characterization of (±)-[3H]R75231 binding to calf lung membranes, stereospecificity of its two stereoisomers, and comparison with [3H]nitrobenzylthioinosine bindingNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
- The relationship between ionization and affinity of nucleoside transport inhibitorsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1990
- Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazineEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Adenosine metabolism in human whole bloodBiochemical Pharmacology, 1988
- Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosineBiochemical Pharmacology, 1985
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodJournal of Pharmacological Methods, 1980
- Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1974
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- The aggregation of blood plateletsThe Journal of Physiology, 1963
- Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood PlateletsNature, 1961